Amyloid- beta 25-35 induces impairment of cognitive function and long-term potentiation through phosphorylation of collapsin response mediator protein 2

• Published in: Neuroscience research Vol. 77; no. 3; pp. 180 - 185
• Main Authors: Isono, Toshinari, Yamashita, Naoya, Obara, Masami, Araki, Tomomi, Nakamura, Fumio, Kamiya, Yoshinori, Alkam, Tursun, Nitta, Atsumi, Nabeshima, Toshitaka, Mikoshiba, Katsuhiko, Ohshima, Toshio, Goshima, Yoshio
• Format: Journal Article
• Language: English
• Published: 01.11.2013
• ISSN: 0168-0102
• DOI: 10.1016/j.neures.2013.08.005

Alzheimer's disease (AD) is characterized by amyloid- beta (A beta ) protein and tau deposition in the brain. Numerous studies have reported a central role of A beta in the development of AD, but the pathogenesis is not well understood. Collapsin response mediator protein 2 (CRMP2), an intracellular protein mediating a repulsive axon guidance molecule, Semaphorin3A, is also accumulated in neurofibrillary tangles in AD brains. To gain insight into the role of CRMP2 phosphorylation in AD pathogenesis, we investigated the effects of A beta neurotoxicity in CRMP2 phosphorylation-deficient knock-in (crmp2ki/ki) mice, in which the serine residue at 522 was replaced with alanine. Intracerebroventricular (i.c.v.) injection of A beta 25-35 peptide, a neurotoxic fragment of A beta protein, to wild-type (wt) mice increased hippocampal phosphorylation of CRMP2. Behavioral assessment revealed that i.c.v. injection of A beta 25-35 peptide caused impairment of novel object recognition in wt mice, while the same peptide did not in crmp2ki/ki mice. In electrophysiological recording, wt and crmp2ki/ki mice have similar input-output basal synaptic transmission and paired-pulse ratios. However, long-term potentiation was impaired in hippocampal slices of A beta 25-35 peptide-treated wt but not those of crmp2ki/ki. Our findings indicate that CRMP2 phosphorylation is required for A beta -induced impairment of cognitive memory and synaptic plasticity.